Literature DB >> 11307662

Newly-formed lymph nodes in the submucosa in chronic inflammatory bowel disease.

E Kaiserling1.   

Abstract

BACKGROUND AND AIMS: Routine diagnostic work revealed cell aggregates reminiscent of lymph nodes in the bowel submucosa in occasional cases of chronic inflammatory bowel disease. We therefore investigated whether they fulfill criteria for classification as lymph nodes.
METHODS: Colon with terminal ileum from a patient with florid Crohn's disease and a colectomy specimen from a patient with ulcerative colitis were investigated. Sections were immunostained with antibodies that recognize endothelial and sinus-lining cells, immune-accessory cells, and lymphoid cells.
RESULTS: Circumscribed collections of cells that fulfill all the major criteria for classification as lymph nodes were found in the large and small bowel. They had marginal and intermediate sinuses (positive for BMA 120, CD34, CD31, X-11, and von Willebrand's factor), afferent lymph vessels, T- and B-regions, and a capsule. Small collections composed predominantly of B cells that had only a marginal sinus were also occasionally observed.
CONCLUSION: Secondary mucosa-associated lymphoid tissue, typically seen as follicular lymphoid hyperplasia, also appears to occur as secondary submucosal lymph nodes. This phenomenon seems inconsistent with the notion that lymph nodes do not develop after birth. We have also noted secondary development of lymph nodes in lymphangioma and lymphangioleiomyomatosis. It is possible that local lymph vessel proliferation, possibly with chronic lymphedema of the tissue involved, is an important prerequisite for lymph node neogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11307662

Source DB:  PubMed          Journal:  Lymphology        ISSN: 0024-7766            Impact factor:   1.286


  26 in total

Review 1.  Nodal staging of colorectal carcinomas and sentinel nodes.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2003-05       Impact factor: 3.411

2.  Increased number of mature dendritic cells in Crohn's disease: evidence for a chemokine mediated retention mechanism.

Authors:  P Middel; D Raddatz; B Gunawan; F Haller; H-J Radzun
Journal:  Gut       Date:  2005-08-23       Impact factor: 23.059

Review 3.  Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals.

Authors:  Daniela Finke
Journal:  Semin Immunopathol       Date:  2009-06-09       Impact factor: 9.623

4.  TNFΔARE Mice Display Abnormal Lymphatics and Develop Tertiary Lymphoid Organs in the Mesentery.

Authors:  Sonia Rehal; Pierre-Yves von der Weid
Journal:  Am J Pathol       Date:  2017-02-06       Impact factor: 4.307

Review 5.  Stromal cell regulation of homeostatic and inflammatory lymphoid organogenesis.

Authors:  Matthew J W Kain; Benjamin M J Owens
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

6.  Inflammation-induced lymphatic architecture and bone turnover changes are ameliorated by irisin treatment in chronic inflammatory bowel disease.

Authors:  S Anand Narayanan; Corinne E Metzger; Susan A Bloomfield; David C Zawieja
Journal:  FASEB J       Date:  2018-03-29       Impact factor: 5.191

7.  CCR6 identifies lymphoid tissue inducer cells within cryptopatches.

Authors:  A Lügering; M Ross; M Sieker; J Heidemann; I R Williams; W Domschke; T Kucharzik
Journal:  Clin Exp Immunol       Date:  2010-02-10       Impact factor: 4.330

8.  Murine isolated lymphoid follicles contain follicular B lymphocytes with a mucosal phenotype.

Authors:  Caihong Wang; Keely G McDonald; Jacquelyn S McDonough; Rodney D Newberry
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-06-15       Impact factor: 4.052

9.  Alpha4beta7/MAdCAM-1 interactions play an essential role in transitioning cryptopatches into isolated lymphoid follicles and a nonessential role in cryptopatch formation.

Authors:  Caihong Wang; Jacquelyn S McDonough; Keely G McDonald; Conway Huang; Rodney D Newberry
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 10.  B Cell-Activating Factor (BAFF)-Targeted B Cell Therapies in Inflammatory Bowel Diseases.

Authors:  Mathieu Uzzan; Jean-Frederic Colombel; Andrea Cerutti; Xavier Treton; Saurabh Mehandru
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.